-
1
المؤلفون: Dante Caposiena, Marco Galluzzo, Eleonora Candi, Luca Bianchi, Gennaro Melino, Annunziata Dattola, Sara Mazzilli, Elisabetta Botti, Elena Campione
المصدر: Health Science Reports
Health Science Reports, Vol 4, Iss 2, Pp n/a-n/a (2021)مصطلحات موضوعية: medicine.medical_specialty, business.industry, General Medicine, Human leukocyte antigen, medicine.disease, Dermatology, Research Letters, Psoriatic arthritis, Settore MED/35, Psoriasis, Ustekinumab, medicine, Adalimumab, Research Letter, Medicine, Methotrexate, Certolizumab pegol, business, Genotyping, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbdad9290e51918419c126b325a9ebeTest
https://pubmed.ncbi.nlm.nih.gov/33977152Test -
2
المؤلفون: Giulio Gualdi, Andrea Conti, Riccardo Balestri, Maria Rita Bongiorno, Annalisa Patrizi, Giuseppe Micali, Paolo Dapavo, Elia Rosi, M.T. Fierro, Luca Bianchi, S. Di Nuzzo, Matteo Megna, Angelo Cattaneo, R. Vezzoni, Francesca Prignano, C. Hansel, Sandra Giustini, Antonio Giovanni Richetta, A. Gambardella, Claudio Guarneri, S.P. Cannavò, Martina Burlando, Luca Stingeni, Giovanna Tilotta, K. Peris, S. Dastoli, Giulia Rech, Giuseppe Argenziano, Claudio Feliciani, Marina Venturini, Angelo V. Marzano, Paolo Gisondi, Giampiero Girolomoni, Mariateresa Rossi, D.M. Gambini, Maurizio Lombardo, Rossana Tiberio, Concetta Potenza, Lidia Sacchelli, Elisabetta Botti, Andrea Carugno, Marco Galluzzo, Paolo Pigatto, Maria Letizia Musumeci, F. Bardazzi, Pietro Quaglino, Pietro Rubegni, Iris Zalaudek, Nicoletta Bernardini, Andrea Chiricozzi, Mark S. Talamonti, Caterina Foti, Giovanni Pellacani, C. De Simone, Emanuele Trovato, Paolo Amerio, Giacomo Caldarola, A. Belloni Fortina, Federico Diotallevi, M C Fargnoli, Francesco Loconsole, Paola Savoia, Arianna Zangrilli, Stefano Piaserico, Andrea Parodi, A. M. Offidani, Steven Paul Nisticò, Gabriella Fabbrocini, Franco Rongioletti, Rosaria Fidanza, Cristina Mugheddu
المساهمون: Talamonti, M., Galluzzo, M., Chiricozzi, A., Quaglino, P., Fabbrocini, G., Gisondi, P., Marzano, A. V., Potenza, C., Conti, A., Parodi, A., Belloni Fortina, A., Bardazzi, F., Argenziano, G., Rongioletti, F., Stingeni, L., Micali, G., Loconsole, F., Venturini, M., Bongiorno, M. R., Feliciani, C., Rubegni, P., Amerio, P., Fargnoli, M. C., Pigatto, P., Savoia, P., Nistico, S. P., Giustini, S., Carugno, A., Cannavo, S. P., Rech, G., Prignano, F., Offidani, A., Lombardo, M., Zalaudek, I., Bianchi, L., Peris, K., Balestri, R., Bernardini, N., Botti, E., Burlando, M., Caldarola, G., Cattaneo, A., Dapavo, P., Dastoli, S., De Simone, C., Di Nuzzo, S., Diotallevi, F., Fierro, M. T., Fidanza, R., Foti, C., Gambini, D. M., Gambardella, A., Girolomoni, G., Guarneri, C., Gualdi, G., Hansel, C., Megna, M., Mugheddu, C., Musumeci, M. L., Patrizi, A., Pellacani, G., Piaserico, S., Richetta, A. G., Rosi, E., Rossi, M. T., Sacchelli, L., Tiberio, R., Tilotta, G., Trovato, E., Vezzoni, R., Zangrilli, A., Talamonti, M, Galluzzo, M, Chiricozzi, A, Quaglino, P, Fabbrocini, G, Gisondi, P, Marzano, A, Potenza, C, Conti, A, Parodi, A, Belloni Fortina, A, Bardazzi, F, Argenziano, G, Rongioletti, F, Stingeni, L, Micali, G, Loconsole, F, Venturini, M, Bongiorno, M, Feliciani, C, Rubegni, P, Amerio, P, Fargnoli, M, Pigatto, P, Savoia, P, Nistico, S, Giustini, S, Carugno, A, Cannavo, S, Rech, G, Prignano, F, Offidani, A, Lombardo, M, Zalaudek, I, Bianchi, L, Peris, K, Balestri, R, Bernardini, N, Botti, E, Burlando, M, Caldarola, G, Cattaneo, A, Dapavo, P, Dastoli, S, De Simone, C, Di Nuzzo, S, Diotallevi, F, Fierro, M, Fidanza, R, Foti, C, Gambini, D, Gambardella, A, Girolomoni, G, Guarneri, C, Gualdi, G, Hansel, K, Megna, M, Mugheddu, C, Musumeci, M, Patrizi, A, Pellacani, G, Piaserico, S, Richetta, A, Rosi, E, Rossi, M, Sacchelli, L, Tiberio, R, Tilotta, G, Trovato, E, Vezzoni, R, Zangrilli, A, Marzano, A V, Bongiorno, Mr, Fargnoli, Mc, Nisticò, Sp, Cannavò, Sp, Fierro, Mt, Gambini, Dm, Musumeci, Ml, Richetta, Ag, Rossi, Mt, Talamonti M., Galluzzo M., Chiricozzi A., Quaglino P., Fabbrocini G., Gisondi P., Marzano A.V., Potenza C., Conti A., Parodi A., Belloni Fortina A., Bardazzi F., Argenziano G., Rongioletti F., Stingeni L., Micali G., Loconsole F., Venturini M., Bongiorno M.R., Feliciani C., Rubegni P., Amerio P., Fargnoli M.C., Pigatto P., Savoia P., Nistico S.P., Giustini S., Carugno A., Cannavo S.P., Rech G., Prignano F., Offidani A., Lombardo M., Zalaudek I., Bianchi L., Peris K., Balestri R., Bernardini N., Botti E., Burlando M., Caldarola G., Cattaneo A., Dapavo P., Dastoli S., De Simone C., Di Nuzzo S., Diotallevi F., Fierro M.T., Fidanza R., Foti C., Gambini D.M., Gambardella A., Girolomoni G., Guarneri C., Gualdi G., Hansel C., Megna M., Mugheddu C., Musumeci M.L., Patrizi A., Pellacani G., Piaserico S., Richetta A.G., Rosi E., Rossi M.T., Sacchelli L., Tiberio R., Tilotta G., Trovato E., Vezzoni R., Zangrilli A.
المصدر: Journal of the European Academy of Dermatology and Venereology
مصطلحات موضوعية: medicine.medical_specialty, Tildrakizumab, Biolgical therapy, COVID-19, Psoriasis, Settore MED/35, Chronic Disease, Emergencies, Humans, Italy, Biological Therapy, Ustekinumab, medicine, Adalimumab, biologics, Intensive care medicine, Letter to the Editor, psoriasi, psoriasis, covid-19, pandemic, Emergencie, Psoriasi, Risankizumab, business.industry, SARS-CoV-2, medicine.disease, dermatology, Ixekizumab, Guselkumab, Infectious Diseases, Secukinumab, business, Settore MED/35 - MALATTIE CUTANEE E VENEREE, biologic, COVID-19, psoriasis, biological therapies, medicine.drug, Human
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6572ed9b6b1bf987e1305b9b150fcc9Test
http://hdl.handle.net/2318/1815307Test -
3
المؤلفون: Raffaele D. CAPOSIENA CARO, Maria V. CANNIZZARO, Cosimo DI RAIMONDO, Eleonora DI MATTEO, Elisabetta BOTTI, Piero ROSSI, Luca BIANCHI
مصطلحات موضوعية: Settore MED/35 - Malattie Cutanee e Veneree, Infectious Diseases, Adalimumab, Anti-Inflammatory Agents, Humans, Dermatology, Severity of Illness Index, Hidradenitis Suppurativa
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe308051587c20143e22b9d05db25a1Test
http://hdl.handle.net/2108/205330Test -
4
المؤلفون: Antonio Costanzo, Elisabetta Botti, Arianna Zangrilli, Antonio Giovanni Richetta, Barbara Marinari, Giulia Spallone, Marina Talamonti, Sergio Chimenti, Mauro Bavetta
المصدر: Drug Development Research. 75:S11-S14
مصطلحات موضوعية: business.industry, Arthritis, medicine.disease, Infliximab, Proinflammatory cytokine, Etanercept, Psoriasis, Rheumatoid arthritis, Drug Discovery, Immunology, Adalimumab, medicine, Tumor necrosis factor alpha, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::369e388974a80811c73d92c8a8504c80Test
https://doi.org/10.1002/ddr.21186Test -
5Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers
المؤلفون: Marina Talamonti, Giulia Spallone, Elisabetta Botti, Sergio Chimenti, Marina Papoutsaki, Antonio Costanzo
المصدر: Dermatology (Basel, Switzerland). 219(1)
مصطلحات موضوعية: Male, Necrosis, Efalizumab, receptors, Gastroenterology, Receptors, Tumor Necrosis Factor, Etanercept, immune system diseases, antigens, antibodies, Treatment Failure, skin and connective tissue diseases, Settore MED/35 - Malattie Cutanee e Veneree, Antibodies, Monoclonal, Middle Aged, Treatment Outcome, Tumor necrosis factor alpha, Female, medicine.symptom, CD11, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Adolescent, tumor necrosis factor, monoclonal, macromolecular substances, Dermatology, Antibodies, Monoclonal, Humanized, Young Adult, Psoriasis, Internal medicine, medicine, Adalimumab, Humans, Aged, business.industry, CD11 Antigens, Tumor Necrosis Factor-alpha, medicine.disease, Infliximab, stomatognathic diseases, treatment outcome, adolescent, male, antigens, CD11, young adult, middle aged, female, dermatologic agents, treatment failure, receptors, tumor necrosis factor, humans, tumor necrosis factor-alpha, immunoglobulin G, psoriasis, aged, adult, antibodies, monoclonal, Immunoglobulin G, Dermatologic Agents, business, Previously treated
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc3db82dbef26a2b00a1146b3d0eb0dfTest
https://pubmed.ncbi.nlm.nih.gov/19372639Test